SCHEMBL26002137

SCHEMBL26002137

CNC(CCCCNC(=O)COC)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.41
▸ FAAH O00519 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ FOLH1 Q04609 1/20 0.35
▸ ALB P02768 3/20 0.35
▸ SPR P35270 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ SIRT6 Q8N6T7 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25355881 0.88 FOLH1 (0.41) TSHRFAAHMEN1KMT2ASMN1; SMN2
SCHEMBL25355885 0.88 FOLH1 (0.41) TSHRFAAHMEN1KMT2ASMN1; SMN2
SCHEMBL1619320 0.87 TSHR (0.43) TSHRFAAHALDH1A1MEN1KMT2A
SCHEMBL18412629 0.83 ALDH1A1 (0.55) TSHRFAAHALDH1A1MEN1KMT2A
SCHEMBL19646650 0.82 FOLH1 (0.44) TSHRALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL21964558 0.82 ALDH1A1 (0.39) TSHRFAAHALDH1A1MEN1KMT2A
SCHEMBL8477259 0.82 ALDH1A1 (0.39) TSHRFAAHALDH1A1MEN1KMT2A
SCHEMBL21964560 0.82 FOLH1 (0.44) TSHRALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL13124556 0.82 MEN1 (0.59) FAAHALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL25968884 0.82 MEN1 (0.59) FAAHALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263900-A1 DENDRIMER-DRUG CONJUGATE STARPHARMA PTY LTD (AU) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263900-A1 DENDRIMER-DRUG CONJUGATE SARS1, MMAB, PAM TSHR 2979/4885FAAH 2384/4885ALDH1A1 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback